Today: 3 June 2026
JPMorgan stock price holds near $322 after hours as jobs, CPI loom
10 February 2026
2 mins read

JPMorgan stock price holds near $322 after hours as jobs, CPI loom

New York, Feb 9, 2026, 17:35 EST — After-hours trading.

  • JPMorgan slipped to $322.10 in after-hours trading, a drop of roughly 0.1% for the session.
  • With U.S. jobs figures coming late and Friday’s CPI looming, traders are on edge over the next rate-cut signal.
  • Troy Rohrbaugh of JPMorgan is scheduled to appear at a UBS conference this Tuesday.

JPMorgan Chase & Co (JPM.N) ended Monday’s after-hours trading more or less flat, changing hands at $322.10. During the regular session, the stock dipped roughly 0.1%. Price action ranged from $320.50 up to $326.37, with volume tallying close to 11.5 million shares.

The real mover is now external. U.S. Treasury yields slipped as traders braced for a busy slate of economic data and fresh bond auctions. Markets are currently factoring in about 50 basis points—half a percentage point—of Fed cuts this year, CME’s FedWatch shows. “The general trajectory for inflation should be modestly lower,” said Bill Merz, who leads capital markets research at U.S. Bank Asset Management Group. London South East

Rate wagers aren’t just a mood swing for the big banks. When long-term rates pull further ahead of short-term ones—a steeper yield curve—that often fattens net interest income, the spread between what banks collect from loans and shell out on deposits.

Stocks ended in the green on Monday. The Dow just managed a fresh record, while the S&P 500 tacked on 0.47%. Investors shrugged off the previous week’s choppiness and shifted focus to the upcoming data slate.

JPMorgan edged down 0.09%, trailing rivals as Bank of New York Mellon climbed 2.65%. Morgan Stanley shares advanced 1.33%, Wells Fargo tacked on 0.68%, market data showed.

Not much on the company news front for now, though investors might find some new clues on Tuesday. According to JPMorgan’s investor relations calendar, Troy Rohrbaugh, co-CEO of the Commercial & Investment Bank, is slated to speak at a conference, with a “Company Update” also on the docket for later this month. JPMorgan Chase

The bank is still working through the balance-sheet impact from its Apple Card exit. Back in January, JPMorgan and Apple made it official: Chase will take over as Apple Card’s issuer, displacing Goldman Sachs. That handover could shift more than $20 billion of card balances to Chase down the line. Goldman CEO David Solomon described it as “substantially completes the narrowing of our focus” for the bank’s consumer unit. Reuters

Back in January, JPMorgan beat fourth-quarter profit estimates as markets revenue jumped—this after the stock logged a 34% gain in 2025. CEO Jamie Dimon pointed to the U.S. economy’s ongoing resilience. CFO Jeremy Barnum echoed the point, telling reporters, “Consumers and small businesses remain resilient.” Reuters

The risk is straightforward: macro conditions could abruptly shift. A stronger inflation number might jolt rate expectations, squeeze valuations, and put funding costs and credit metrics under the microscope — card portfolios are especially exposed, as losses can pile up quickly when things turn south.

On deck: the U.S. jobs report lands Wednesday, followed by Friday’s consumer price index, both hitting at 8:30 a.m. Eastern. Traders are keyed in, scanning for signs of any rate path adjustment.

Latest articles

Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Lags Nasdaq, Turnaround Pressure Rises

3 June 2026
Snap Inc. shares slid 1.5% to $5.76 Tuesday—about 45% below last July’s high—even as the broader market rose, spotlighting investor doubts about Snap’s turnaround despite first-quarter revenue growth, narrowed losses, and major cost cuts; ad growth remains sluggish and the upcoming Specs update on June 16 is seen as a key test for future revenue momentum.
INFQ back on radar after UK quantum push; shares jump

INFQ back on radar after UK quantum push; shares jump

3 June 2026
Infleqtion shares surged 12.4% to $19.87 in late New York trading after announcing Gold Sponsorship of Quantum Fringe 2026 and new U.K. quantum partnerships, as investors bet on government contracts and expanded manufacturing, despite a $30.3 million quarterly net loss and warnings of ongoing operating losses if public-sector funding slows.
Corning shares move after AI news

Corning shares move after AI news

3 June 2026
Corning soared 13.4% to $200.40 on heavy volume after Nvidia’s CEO spotlighted the need for optical links in AI data centers, with Corning’s recent Nvidia and Meta deals making it a top play on AI infrastructure; first-quarter core sales jumped 18% and optical sales surged 36%, but investors face risks from consumer electronics demand and execution on new factory expansions.
Quantum computing stocks face a holiday week after IonQ stake filing and a Rigetti downgrade

IonQ Stock Jumped Again. A Giant Quantum IPO Is Putting the Trade on Trial

3 June 2026
IonQ shares closed up 3.1% at $71.40 before slipping 1.3% after hours as traders positioned ahead of Quantinuum’s upsized IPO, which seeks up to $1.46 billion at a $14.3 billion valuation; IonQ’s Q1 revenue surged 755% to $64.7 million with a raised 2026 outlook, but a $271.5 million operating loss and guidance for continued high expenses highlight risks as Wall Street awaits new sector benchmarks.
Xos Surges After Hours as Data-Center Power Play Hits Tape

Xos Surges After Hours as Data-Center Power Play Hits Tape

3 June 2026
Xos shares soared 135.8% to $5.26 in after-hours trading after launching a 2.5MWh Power Hub for data centers facing grid delays, but the company warned of "substantial doubt" about its ability to continue as a going concern, with just $9.8 million in cash at March 31 and no large orders yet announced for the new product.
AppLovin stock price jumps after CapitalWatch apology as APP earnings loom
Previous Story

AppLovin stock price jumps after CapitalWatch apology as APP earnings loom

Hims & Hers stock sinks after $49 Wegovy copycat U-turn and Novo Nordisk lawsuit
Next Story

Hims & Hers stock sinks after $49 Wegovy copycat U-turn and Novo Nordisk lawsuit

Go toTop